Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes

Volume: 69, Issue: 4, Pages: 532 - 541
Published: Apr 1, 2020
Abstract
Glucagon is historically described as the counterregulatory hormone to insulin, induced by fasting/hypoglycemia to raise blood glucose through action mediated in the liver. However, it is becoming clear that the biology of glucagon is much more complex and extends beyond hepatic actions to exert control on glucose metabolism. We discuss the inconsistencies with the canonical view that glucagon is primarily a hyperglycemic agent driven by...
Paper Details
Title
Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes
Published Date
Apr 1, 2020
Journal
Volume
69
Issue
4
Pages
532 - 541
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.